SAFE vs convertible note comes down to one structural difference. A convertible note is debt, with interest and a maturity date. A SAFE is a contract for future equity that carries neither. The market has largely chosen: Carta data shows convertible notes fell to 7 percent of U.S. pre-seed rounds in Q1 2026.
Choosing the popular instrument still leaves real decisions on the table. What you sign sets your dilution math, your obligations if the next round never arrives, and how clean the cap table looks when a Series A lead opens the data room. Here is how each one works, and where each still fits.
Converting to equity: how a SAFE and a convertible note each work
Both instruments let a startup take money today and set the share price later, usually at the next priced round. The convertible note gets there as a loan. The SEC's investor bulletin describes notes as debt obligations that carry "a promise of repayment, interest on the loan for a period of time and an ability to convert" into equity, and says they generally represent a current legal obligation of the company (SEC Investor.gov).
The SAFE skips the loan. Y Combinator introduced it in 2013 and released the post-money version in 2018, and it publishes three standard U.S. forms: valuation cap with no discount, discount with no cap, and an uncapped most-favored-nation version (Y Combinator). Because a SAFE has no maturity date, nobody has to renegotiate an expiring instrument. For the wider fundraising sequence around either one, see our startup fundraising guide.
The 2026 pre-seed data shows the SAFE has become the default
Carta's Q1 2026 pre-seed report calls SAFEs the default financing instrument for early-stage startups, with convertible notes at a record low of 7 percent of rounds and 8 percent of dollars (Carta). A founder offering a note in 2026 is asking investors to use paperwork most of them see less and less.
The size of each SAFE is climbing too. U.S. startups on Carta raised $3.19 billion across more than 11,500 pre-seed instruments in Q2 2026, against $3.22 billion across 14,825 a year earlier, which pushed the average instrument to a record $276,000, up 27 percent year over year (Carta). Fewer, larger checks mean each SAFE carries more dilution, a pattern tied closely to the concentration of AI funding that took 49 percent of pre-seed dollars in the first half.
Post-money SAFE dilution is simple to calculate and easy to underestimate
The post-money SAFE was built so founders can see exactly what they sold. Y Combinator measures SAFE ownership after all the SAFE money is counted, and describes the ownership sold as the investment amount divided by the valuation cap (Y Combinator). A $500,000 SAFE on a $5 million post-money cap buys 10 percent, before the priced round dilutes everyone.
The trap is stacking. Each post-money SAFE locks in its own percentage, so every additional SAFE comes out of the founders' share. Carta found that pre-seed deals above $2.5 million typically stack ten or more instruments, and that caps on the largest SAFEs reach $100 million at the 90th percentile (Carta). Model the pro forma cap table after every signature. If you want a second set of eyes on the model, our funding and incubation team does this work with founders every quarter.
A convertible note still beats a SAFE in a few situations
A convertible note still earns its place in a few situations. Some angels and family offices want the standing of a creditor, and a note gives them a repayment claim the SAFE does not. Existing investors bridging a company between priced rounds often prefer a note for the same reason. Location matters as well: Y Combinator publishes non-U.S. SAFE forms only for Canada, the Cayman Islands and Singapore (Y Combinator), so companies formed elsewhere may find local counsel more comfortable with a note.
The costs are the ones YC designed the SAFE to remove. Interest accrues and converts into additional shares. The maturity date arrives on schedule whether or not the next round does, and extending it means reopening terms with every holder. If you choose a note, set the maturity far enough out to cover a realistic raise timeline, and agree in writing what happens at maturity before anyone wires money.
The SAFE risks founders and investors tend to miss
The SEC put it bluntly: "Despite its name, a SAFE may not be 'simple' or 'safe'" (SEC Investor.gov). A SAFE converts only when its trigger fires. The bulletin notes that if a company later raises money by selling more SAFEs, common stock or convertible notes, a SAFE that triggers on preferred stock will not convert, and holders can wait indefinitely.
For founders, that open-ended quality creates cap table overhang. Investors in the next round will want to see every outstanding SAFE, its cap, its discount, and any side letters granting pro rata rights. Keep one register of every instrument from the first check. Unit economics shape how long you can wait between rounds, which is why network economics for AI startups belongs in the same planning conversation.
Choosing between a SAFE and a convertible note for your round
Four questions settle most decisions. How soon is a priced round realistic? Who are the investors, and what do they sign by default? Where is the company incorporated? And how much are you raising in total across every instrument? If the round is U.S.-incorporated, the investors are venture funds, and the next priced round is plausible within two years, the post-money SAFE with a valuation cap is the market standard, and YC notes the cap is usually the only term to negotiate (Y Combinator).
Whatever you sign, the capital buys runway to prove a go-to-market motion, and investors in the next round will judge that motion first. Many seed-stage teams bring in a fractional CMO to build the growth plan that justifies the next valuation. If you are weighing instruments and want to pressure-test the plan behind the raise, talk to our team. Nothing here is legal or investment advice; have a startup lawyer review any financing document before you sign.
